1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Artificial Intelligence-driven Drug Development Market Size (2020-2031) 2.1.2 Artificial Intelligence-driven Drug Development Market Size CAGR by Region (2020 VS 2024 VS 2031) 2.1.3 World Current & Future Analysis for Artificial Intelligence-driven Drug Development by Country/Region (2020, 2024 & 2031) 2.2 Artificial Intelligence-driven Drug Development Segment by Type 2.2.1 Hardware 2.2.2 Software 2.2.3 Service 2.3 Artificial Intelligence-driven Drug Development Market Size by Type 2.3.1 Artificial Intelligence-driven Drug Development Market Size CAGR by Type (2020 VS 2024 VS 2031) 2.3.2 Global Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2020-2025) 2.4 Artificial Intelligence-driven Drug Development Segment by Application 2.4.1 Early Drug Discovery 2.4.2 Preclinical Phase 2.4.3 Clinical Phase 2.4.4 Regulatory Approval 2.5 Artificial Intelligence-driven Drug Development Market Size by Application 2.5.1 Artificial Intelligence-driven Drug Development Market Size CAGR by Application (2020 VS 2024 VS 2031) 2.5.2 Global Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2020-2025) 3 Artificial Intelligence-driven Drug Development Market Size by Player 3.1 Artificial Intelligence-driven Drug Development Market Size Market Share by Player 3.1.1 Global Artificial Intelligence-driven Drug Development Revenue by Player (2020-2025) 3.1.2 Global Artificial Intelligence-driven Drug Development Revenue Market Share by Player (2020-2025) 3.2 Global Artificial Intelligence-driven Drug Development Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Artificial Intelligence-driven Drug Development by Region 4.1 Artificial Intelligence-driven Drug Development Market Size by Region (2020-2025) 4.2 Global Artificial Intelligence-driven Drug Development Annual Revenue by Country/Region (2020-2025) 4.3 Americas Artificial Intelligence-driven Drug Development Market Size Growth (2020-2025) 4.4 APAC Artificial Intelligence-driven Drug Development Market Size Growth (2020-2025) 4.5 Europe Artificial Intelligence-driven Drug Development Market Size Growth (2020-2025) 4.6 Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Growth (2020-2025) 5 Americas 5.1 Americas Artificial Intelligence-driven Drug Development Market Size by Country (2020-2025) 5.2 Americas Artificial Intelligence-driven Drug Development Market Size by Type (2020-2025) 5.3 Americas Artificial Intelligence-driven Drug Development Market Size by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Artificial Intelligence-driven Drug Development Market Size by Region (2020-2025) 6.2 APAC Artificial Intelligence-driven Drug Development Market Size by Type (2020-2025) 6.3 APAC Artificial Intelligence-driven Drug Development Market Size by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Artificial Intelligence-driven Drug Development Market Size by Country (2020-2025) 7.2 Europe Artificial Intelligence-driven Drug Development Market Size by Type (2020-2025) 7.3 Europe Artificial Intelligence-driven Drug Development Market Size by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Artificial Intelligence-driven Drug Development by Region (2020-2025) 8.2 Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Type (2020-2025) 8.3 Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Artificial Intelligence-driven Drug Development Market Forecast 10.1 Global Artificial Intelligence-driven Drug Development Forecast by Region (2026-2031) 10.1.1 Global Artificial Intelligence-driven Drug Development Forecast by Region (2026-2031) 10.1.2 Americas Artificial Intelligence-driven Drug Development Forecast 10.1.3 APAC Artificial Intelligence-driven Drug Development Forecast 10.1.4 Europe Artificial Intelligence-driven Drug Development Forecast 10.1.5 Middle East & Africa Artificial Intelligence-driven Drug Development Forecast 10.2 Americas Artificial Intelligence-driven Drug Development Forecast by Country (2026-2031) 10.2.1 United States Market Artificial Intelligence-driven Drug Development Forecast 10.2.2 Canada Market Artificial Intelligence-driven Drug Development Forecast 10.2.3 Mexico Market Artificial Intelligence-driven Drug Development Forecast 10.2.4 Brazil Market Artificial Intelligence-driven Drug Development Forecast 10.3 APAC Artificial Intelligence-driven Drug Development Forecast by Region (2026-2031) 10.3.1 China Artificial Intelligence-driven Drug Development Market Forecast 10.3.2 Japan Market Artificial Intelligence-driven Drug Development Forecast 10.3.3 Korea Market Artificial Intelligence-driven Drug Development Forecast 10.3.4 Southeast Asia Market Artificial Intelligence-driven Drug Development Forecast 10.3.5 India Market Artificial Intelligence-driven Drug Development Forecast 10.3.6 Australia Market Artificial Intelligence-driven Drug Development Forecast 10.4 Europe Artificial Intelligence-driven Drug Development Forecast by Country (2026-2031) 10.4.1 Germany Market Artificial Intelligence-driven Drug Development Forecast 10.4.2 France Market Artificial Intelligence-driven Drug Development Forecast 10.4.3 UK Market Artificial Intelligence-driven Drug Development Forecast 10.4.4 Italy Market Artificial Intelligence-driven Drug Development Forecast 10.4.5 Russia Market Artificial Intelligence-driven Drug Development Forecast 10.5 Middle East & Africa Artificial Intelligence-driven Drug Development Forecast by Region (2026-2031) 10.5.1 Egypt Market Artificial Intelligence-driven Drug Development Forecast 10.5.2 South Africa Market Artificial Intelligence-driven Drug Development Forecast 10.5.3 Israel Market Artificial Intelligence-driven Drug Development Forecast 10.5.4 Turkey Market Artificial Intelligence-driven Drug Development Forecast 10.6 Global Artificial Intelligence-driven Drug Development Forecast by Type (2026-2031) 10.7 Global Artificial Intelligence-driven Drug Development Forecast by Application (2026-2031) 10.7.1 GCC Countries Market Artificial Intelligence-driven Drug Development Forecast 11 Key Players Analysis 11.1 IBM 11.1.1 IBM Company Information 11.1.2 IBM Artificial Intelligence-driven Drug Development Product Offered 11.1.3 IBM Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.1.4 IBM Main Business Overview 11.1.5 IBM Latest Developments 11.2 Exscientia 11.2.1 Exscientia Company Information 11.2.2 Exscientia Artificial Intelligence-driven Drug Development Product Offered 11.2.3 Exscientia Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.2.4 Exscientia Main Business Overview 11.2.5 Exscientia Latest Developments 11.3 Google(Alphabet) 11.3.1 Google(Alphabet) Company Information 11.3.2 Google(Alphabet) Artificial Intelligence-driven Drug Development Product Offered 11.3.3 Google(Alphabet) Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.3.4 Google(Alphabet) Main Business Overview 11.3.5 Google(Alphabet) Latest Developments 11.4 Microsoft 11.4.1 Microsoft Company Information 11.4.2 Microsoft Artificial Intelligence-driven Drug Development Product Offered 11.4.3 Microsoft Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.4.4 Microsoft Main Business Overview 11.4.5 Microsoft Latest Developments 11.5 Atomwise 11.5.1 Atomwise Company Information 11.5.2 Atomwise Artificial Intelligence-driven Drug Development Product Offered 11.5.3 Atomwise Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.5.4 Atomwise Main Business Overview 11.5.5 Atomwise Latest Developments 11.6 Schrodinger 11.6.1 Schrodinger Company Information 11.6.2 Schrodinger Artificial Intelligence-driven Drug Development Product Offered 11.6.3 Schrodinger Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.6.4 Schrodinger Main Business Overview 11.6.5 Schrodinger Latest Developments 11.7 Aitia 11.7.1 Aitia Company Information 11.7.2 Aitia Artificial Intelligence-driven Drug Development Product Offered 11.7.3 Aitia Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.7.4 Aitia Main Business Overview 11.7.5 Aitia Latest Developments 11.8 Insilico Medicine 11.8.1 Insilico Medicine Company Information 11.8.2 Insilico Medicine Artificial Intelligence-driven Drug Development Product Offered 11.8.3 Insilico Medicine Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.8.4 Insilico Medicine Main Business Overview 11.8.5 Insilico Medicine Latest Developments 11.9 NVIDIA 11.9.1 NVIDIA Company Information 11.9.2 NVIDIA Artificial Intelligence-driven Drug Development Product Offered 11.9.3 NVIDIA Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.9.4 NVIDIA Main Business Overview 11.9.5 NVIDIA Latest Developments 11.10 XtalPi 11.10.1 XtalPi Company Information 11.10.2 XtalPi Artificial Intelligence-driven Drug Development Product Offered 11.10.3 XtalPi Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.10.4 XtalPi Main Business Overview 11.10.5 XtalPi Latest Developments 11.11 BPGbio 11.11.1 BPGbio Company Information 11.11.2 BPGbio Artificial Intelligence-driven Drug Development Product Offered 11.11.3 BPGbio Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.11.4 BPGbio Main Business Overview 11.11.5 BPGbio Latest Developments 11.12 Owkin 11.12.1 Owkin Company Information 11.12.2 Owkin Artificial Intelligence-driven Drug Development Product Offered 11.12.3 Owkin Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.12.4 Owkin Main Business Overview 11.12.5 Owkin Latest Developments 11.13 CytoReason 11.13.1 CytoReason Company Information 11.13.2 CytoReason Artificial Intelligence-driven Drug Development Product Offered 11.13.3 CytoReason Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.13.4 CytoReason Main Business Overview 11.13.5 CytoReason Latest Developments 11.14 Deep Genomics 11.14.1 Deep Genomics Company Information 11.14.2 Deep Genomics Artificial Intelligence-driven Drug Development Product Offered 11.14.3 Deep Genomics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.14.4 Deep Genomics Main Business Overview 11.14.5 Deep Genomics Latest Developments 11.15 Cloud Pharmaceuticals 11.15.1 Cloud Pharmaceuticals Company Information 11.15.2 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Product Offered 11.15.3 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.15.4 Cloud Pharmaceuticals Main Business Overview 11.15.5 Cloud Pharmaceuticals Latest Developments 11.16 BenevolentAI 11.16.1 BenevolentAI Company Information 11.16.2 BenevolentAI Artificial Intelligence-driven Drug Development Product Offered 11.16.3 BenevolentAI Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.16.4 BenevolentAI Main Business Overview 11.16.5 BenevolentAI Latest Developments 11.17 Cyclica 11.17.1 Cyclica Company Information 11.17.2 Cyclica Artificial Intelligence-driven Drug Development Product Offered 11.17.3 Cyclica Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.17.4 Cyclica Main Business Overview 11.17.5 Cyclica Latest Developments 11.18 Verge Genomics 11.18.1 Verge Genomics Company Information 11.18.2 Verge Genomics Artificial Intelligence-driven Drug Development Product Offered 11.18.3 Verge Genomics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.18.4 Verge Genomics Main Business Overview 11.18.5 Verge Genomics Latest Developments 11.19 Valo Health 11.19.1 Valo Health Company Information 11.19.2 Valo Health Artificial Intelligence-driven Drug Development Product Offered 11.19.3 Valo Health Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.19.4 Valo Health Main Business Overview 11.19.5 Valo Health Latest Developments 11.20 Envisagenics 11.20.1 Envisagenics Company Information 11.20.2 Envisagenics Artificial Intelligence-driven Drug Development Product Offered 11.20.3 Envisagenics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.20.4 Envisagenics Main Business Overview 11.20.5 Envisagenics Latest Developments 11.21 Euretos 11.21.1 Euretos Company Information 11.21.2 Euretos Artificial Intelligence-driven Drug Development Product Offered 11.21.3 Euretos Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.21.4 Euretos Main Business Overview 11.21.5 Euretos Latest Developments 11.22 BioAge Labs 11.22.1 BioAge Labs Company Information 11.22.2 BioAge Labs Artificial Intelligence-driven Drug Development Product Offered 11.22.3 BioAge Labs Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.22.4 BioAge Labs Main Business Overview 11.22.5 BioAge Labs Latest Developments 11.23 Iktos 11.23.1 Iktos Company Information 11.23.2 Iktos Artificial Intelligence-driven Drug Development Product Offered 11.23.3 Iktos Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.23.4 Iktos Main Business Overview 11.23.5 Iktos Latest Developments 11.24 BioSymetrics 11.24.1 BioSymetrics Company Information 11.24.2 BioSymetrics Artificial Intelligence-driven Drug Development Product Offered 11.24.3 BioSymetrics Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.24.4 BioSymetrics Main Business Overview 11.24.5 BioSymetrics Latest Developments 11.25 Evaxion Biotech 11.25.1 Evaxion Biotech Company Information 11.25.2 Evaxion Biotech Artificial Intelligence-driven Drug Development Product Offered 11.25.3 Evaxion Biotech Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.25.4 Evaxion Biotech Main Business Overview 11.25.5 Evaxion Biotech Latest Developments 11.26 Aria Pharmaceuticals 11.26.1 Aria Pharmaceuticals Company Information 11.26.2 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Product Offered 11.26.3 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue, Gross Margin and Market Share (2020-2025) 11.26.4 Aria Pharmaceuticals Main Business Overview 11.26.5 Aria Pharmaceuticals Latest Developments 12 Research Findings and Conclusion
List of Tables Table 1. Artificial Intelligence-driven Drug Development Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions) Table 2. Artificial Intelligence-driven Drug Development Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of Hardware Table 4. Major Players of Software Table 5. Major Players of Service Table 6. Artificial Intelligence-driven Drug Development Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions) Table 7. Global Artificial Intelligence-driven Drug Development Market Size by Type (2020-2025) & ($ millions) Table 8. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2020-2025) Table 9. Artificial Intelligence-driven Drug Development Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions) Table 10. Global Artificial Intelligence-driven Drug Development Market Size by Application (2020-2025) & ($ millions) Table 11. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2020-2025) Table 12. Global Artificial Intelligence-driven Drug Development Revenue by Player (2020-2025) & ($ millions) Table 13. Global Artificial Intelligence-driven Drug Development Revenue Market Share by Player (2020-2025) Table 14. Artificial Intelligence-driven Drug Development Key Players Head office and Products Offered Table 15. Artificial Intelligence-driven Drug Development Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Artificial Intelligence-driven Drug Development Market Size by Region (2020-2025) & ($ millions) Table 19. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Region (2020-2025) Table 20. Global Artificial Intelligence-driven Drug Development Revenue by Country/Region (2020-2025) & ($ millions) Table 21. Global Artificial Intelligence-driven Drug Development Revenue Market Share by Country/Region (2020-2025) Table 22. Americas Artificial Intelligence-driven Drug Development Market Size by Country (2020-2025) & ($ millions) Table 23. Americas Artificial Intelligence-driven Drug Development Market Size Market Share by Country (2020-2025) Table 24. Americas Artificial Intelligence-driven Drug Development Market Size by Type (2020-2025) & ($ millions) Table 25. Americas Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2020-2025) Table 26. Americas Artificial Intelligence-driven Drug Development Market Size by Application (2020-2025) & ($ millions) Table 27. Americas Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2020-2025) Table 28. APAC Artificial Intelligence-driven Drug Development Market Size by Region (2020-2025) & ($ millions) Table 29. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Region (2020-2025) Table 30. APAC Artificial Intelligence-driven Drug Development Market Size by Type (2020-2025) & ($ millions) Table 31. APAC Artificial Intelligence-driven Drug Development Market Size by Application (2020-2025) & ($ millions) Table 32. Europe Artificial Intelligence-driven Drug Development Market Size by Country (2020-2025) & ($ millions) Table 33. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Country (2020-2025) Table 34. Europe Artificial Intelligence-driven Drug Development Market Size by Type (2020-2025) & ($ millions) Table 35. Europe Artificial Intelligence-driven Drug Development Market Size by Application (2020-2025) & ($ millions) Table 36. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Region (2020-2025) & ($ millions) Table 37. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Type (2020-2025) & ($ millions) Table 38. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Application (2020-2025) & ($ millions) Table 39. Key Market Drivers & Growth Opportunities of Artificial Intelligence-driven Drug Development Table 40. Key Market Challenges & Risks of Artificial Intelligence-driven Drug Development Table 41. Key Industry Trends of Artificial Intelligence-driven Drug Development Table 42. Global Artificial Intelligence-driven Drug Development Market Size Forecast by Region (2026-2031) & ($ millions) Table 43. Global Artificial Intelligence-driven Drug Development Market Size Market Share Forecast by Region (2026-2031) Table 44. Global Artificial Intelligence-driven Drug Development Market Size Forecast by Type (2026-2031) & ($ millions) Table 45. Global Artificial Intelligence-driven Drug Development Market Size Forecast by Application (2026-2031) & ($ millions) Table 46. IBM Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 47. IBM Artificial Intelligence-driven Drug Development Product Offered Table 48. IBM Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 49. IBM Main Business Table 50. IBM Latest Developments Table 51. Exscientia Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 52. Exscientia Artificial Intelligence-driven Drug Development Product Offered Table 53. Exscientia Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 54. Exscientia Main Business Table 55. Exscientia Latest Developments Table 56. Google(Alphabet) Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 57. Google(Alphabet) Artificial Intelligence-driven Drug Development Product Offered Table 58. Google(Alphabet) Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 59. Google(Alphabet) Main Business Table 60. Google(Alphabet) Latest Developments Table 61. Microsoft Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 62. Microsoft Artificial Intelligence-driven Drug Development Product Offered Table 63. Microsoft Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 64. Microsoft Main Business Table 65. Microsoft Latest Developments Table 66. Atomwise Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 67. Atomwise Artificial Intelligence-driven Drug Development Product Offered Table 68. Atomwise Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 69. Atomwise Main Business Table 70. Atomwise Latest Developments Table 71. Schrodinger Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 72. Schrodinger Artificial Intelligence-driven Drug Development Product Offered Table 73. Schrodinger Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 74. Schrodinger Main Business Table 75. Schrodinger Latest Developments Table 76. Aitia Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 77. Aitia Artificial Intelligence-driven Drug Development Product Offered Table 78. Aitia Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 79. Aitia Main Business Table 80. Aitia Latest Developments Table 81. Insilico Medicine Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 82. Insilico Medicine Artificial Intelligence-driven Drug Development Product Offered Table 83. Insilico Medicine Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 84. Insilico Medicine Main Business Table 85. Insilico Medicine Latest Developments Table 86. NVIDIA Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 87. NVIDIA Artificial Intelligence-driven Drug Development Product Offered Table 88. NVIDIA Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 89. NVIDIA Main Business Table 90. NVIDIA Latest Developments Table 91. XtalPi Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 92. XtalPi Artificial Intelligence-driven Drug Development Product Offered Table 93. XtalPi Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 94. XtalPi Main Business Table 95. XtalPi Latest Developments Table 96. BPGbio Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 97. BPGbio Artificial Intelligence-driven Drug Development Product Offered Table 98. BPGbio Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 99. BPGbio Main Business Table 100. BPGbio Latest Developments Table 101. Owkin Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 102. Owkin Artificial Intelligence-driven Drug Development Product Offered Table 103. Owkin Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 104. Owkin Main Business Table 105. Owkin Latest Developments Table 106. CytoReason Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 107. CytoReason Artificial Intelligence-driven Drug Development Product Offered Table 108. CytoReason Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 109. CytoReason Main Business Table 110. CytoReason Latest Developments Table 111. Deep Genomics Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 112. Deep Genomics Artificial Intelligence-driven Drug Development Product Offered Table 113. Deep Genomics Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 114. Deep Genomics Main Business Table 115. Deep Genomics Latest Developments Table 116. Cloud Pharmaceuticals Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 117. Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Product Offered Table 118. Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 119. Cloud Pharmaceuticals Main Business Table 120. Cloud Pharmaceuticals Latest Developments Table 121. BenevolentAI Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 122. BenevolentAI Artificial Intelligence-driven Drug Development Product Offered Table 123. BenevolentAI Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 124. BenevolentAI Main Business Table 125. BenevolentAI Latest Developments Table 126. Cyclica Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 127. Cyclica Artificial Intelligence-driven Drug Development Product Offered Table 128. Cyclica Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 129. Cyclica Main Business Table 130. Cyclica Latest Developments Table 131. Verge Genomics Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 132. Verge Genomics Artificial Intelligence-driven Drug Development Product Offered Table 133. Verge Genomics Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 134. Verge Genomics Main Business Table 135. Verge Genomics Latest Developments Table 136. Valo Health Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 137. Valo Health Artificial Intelligence-driven Drug Development Product Offered Table 138. Valo Health Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 139. Valo Health Main Business Table 140. Valo Health Latest Developments Table 141. Envisagenics Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 142. Envisagenics Artificial Intelligence-driven Drug Development Product Offered Table 143. Envisagenics Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 144. Envisagenics Main Business Table 145. Envisagenics Latest Developments Table 146. Euretos Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 147. Euretos Artificial Intelligence-driven Drug Development Product Offered Table 148. Euretos Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 149. Euretos Main Business Table 150. Euretos Latest Developments Table 151. BioAge Labs Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 152. BioAge Labs Artificial Intelligence-driven Drug Development Product Offered Table 153. BioAge Labs Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 154. BioAge Labs Main Business Table 155. BioAge Labs Latest Developments Table 156. Iktos Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 157. Iktos Artificial Intelligence-driven Drug Development Product Offered Table 158. Iktos Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 159. Iktos Main Business Table 160. Iktos Latest Developments Table 161. BioSymetrics Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 162. BioSymetrics Artificial Intelligence-driven Drug Development Product Offered Table 163. BioSymetrics Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 164. BioSymetrics Main Business Table 165. BioSymetrics Latest Developments Table 166. Evaxion Biotech Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 167. Evaxion Biotech Artificial Intelligence-driven Drug Development Product Offered Table 168. Evaxion Biotech Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 169. Evaxion Biotech Main Business Table 170. Evaxion Biotech Latest Developments Table 171. Aria Pharmaceuticals Details, Company Type, Artificial Intelligence-driven Drug Development Area Served and Its Competitors Table 172. Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Product Offered Table 173. Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 174. Aria Pharmaceuticals Main Business Table 175. Aria Pharmaceuticals Latest Developments List of Figures Figure 1. Artificial Intelligence-driven Drug Development Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Artificial Intelligence-driven Drug Development Market Size Growth Rate (2020-2031) ($ millions) Figure 6. Artificial Intelligence-driven Drug Development Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 7. Artificial Intelligence-driven Drug Development Sales Market Share by Country/Region (2024) Figure 8. Artificial Intelligence-driven Drug Development Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 9. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Type in 2024 Figure 10. Artificial Intelligence-driven Drug Development in Early Drug Discovery Figure 11. Global Artificial Intelligence-driven Drug Development Market: Early Drug Discovery (2020-2025) & ($ millions) Figure 12. Artificial Intelligence-driven Drug Development in Preclinical Phase Figure 13. Global Artificial Intelligence-driven Drug Development Market: Preclinical Phase (2020-2025) & ($ millions) Figure 14. Artificial Intelligence-driven Drug Development in Clinical Phase Figure 15. Global Artificial Intelligence-driven Drug Development Market: Clinical Phase (2020-2025) & ($ millions) Figure 16. Artificial Intelligence-driven Drug Development in Regulatory Approval Figure 17. Global Artificial Intelligence-driven Drug Development Market: Regulatory Approval (2020-2025) & ($ millions) Figure 18. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Application in 2024 Figure 19. Global Artificial Intelligence-driven Drug Development Revenue Market Share by Player in 2024 Figure 20. Global Artificial Intelligence-driven Drug Development Market Size Market Share by Region (2020-2025) Figure 21. Americas Artificial Intelligence-driven Drug Development Market Size 2020-2025 ($ millions) Figure 22. APAC Artificial Intelligence-driven Drug Development Market Size 2020-2025 ($ millions) Figure 23. Europe Artificial Intelligence-driven Drug Development Market Size 2020-2025 ($ millions) Figure 24. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size 2020-2025 ($ millions) Figure 25. Americas Artificial Intelligence-driven Drug Development Value Market Share by Country in 2024 Figure 26. United States Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 27. Canada Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 28. Mexico Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 29. Brazil Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 30. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Region in 2024 Figure 31. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2020-2025) Figure 32. APAC Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2020-2025) Figure 33. China Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 34. Japan Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 35. South Korea Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 36. Southeast Asia Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 37. India Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 38. Australia Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 39. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Country in 2024 Figure 40. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2020-2025) Figure 41. Europe Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2020-2025) Figure 42. Germany Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 43. France Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 44. UK Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 45. Italy Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 46. Russia Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 47. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Region (2020-2025) Figure 48. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2020-2025) Figure 49. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Market Share by Application (2020-2025) Figure 50. Egypt Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 51. South Africa Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 52. Israel Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 53. Turkey Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 54. GCC Countries Artificial Intelligence-driven Drug Development Market Size Growth 2020-2025 ($ millions) Figure 55. Americas Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 56. APAC Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 57. Europe Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 58. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 59. United States Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 60. Canada Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 61. Mexico Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 62. Brazil Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 63. China Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 64. Japan Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 65. Korea Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 66. Southeast Asia Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 67. India Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 68. Australia Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 69. Germany Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 70. France Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 71. UK Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 72. Italy Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 73. Russia Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 74. Egypt Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 75. South Africa Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 76. Israel Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 77. Turkey Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions) Figure 78. Global Artificial Intelligence-driven Drug Development Market Size Market Share Forecast by Type (2026-2031) Figure 79. Global Artificial Intelligence-driven Drug Development Market Size Market Share Forecast by Application (2026-2031) Figure 80. GCC Countries Artificial Intelligence-driven Drug Development Market Size 2026-2031 ($ millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
IBM|||Exscientia|||Google(Alphabet)|||Microsoft|||Atomwise|||Schrodinger|||Aitia|||Insilico Medicine|||NVIDIA|||XtalPi|||BPGbio|||Owkin|||CytoReason|||Deep Genomics|||Cloud Pharmaceuticals|||BenevolentAI|||Cyclica|||Verge Genomics|||Valo Health|||Envisagenics|||Euretos|||BioAge Labs|||Iktos|||BioSymetrics|||Evaxion Biotech|||Aria Pharmaceuticals